Gary D. Glick
Affiliations: | Biological Chemistry | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
anti-DNA autoantibody structure and function, and the identification of novel molecular targets and small molecules for the treatment of autoimmune diseases and cancerWebsite:
https://www.chem.lsa.umich.edu/chem/faculty/facultyDetail.php?Uniqname=gglickGoogle:
"Gary D. Glick"Bio:
http://www.biochem.med.umich.edu/?q=glick
http://www.sfrrimeeting.org/bio-glick.html
Mean distance: 7.45
Cross-listing: MichiganTree
Parents
Sign in to add mentorW. Clark Still | grad student | 1988 | Columbia | |
(Design, synthesis, and conformational analysis of a novel host for peptide substrates) | ||||
Jeremy R. Knowles | post-doc | 1990 | Harvard |
Children
Sign in to add traineePatricia C. Ackroyd | grad student | 2001 | University of Michigan |
Neal B. Blatt | grad student | 2002 | University of Michigan |
Joanne Cleary | grad student | 2002 | University of Michigan |
Jeffrey J. Bednarski | grad student | 2003 | University of Michigan |
Anthony E. Boitano | grad student | 2005 | University of Michigan |
Kathryn M. Johnson | grad student | 2005 | University of Michigan |
Melissa J. Bobeck | grad student | 2007 | University of Michigan |
Thomas B. Sundberg | grad student | 2009 | University of Michigan |
Tasha M. Francis | grad student | 2010 | University of Michigan |
Daniel R. Wahl | grad student | 2012 | University of Michigan |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mangan MSJ, Olhava EJ, Roush WR, et al. (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nature Reviews. Drug Discovery |
Starke I, Glick GD, Börsch M. (2018) Visualizing Mitochondrial FF-ATP Synthase as the Target of the Immunomodulatory Drug Bz-423. Frontiers in Physiology. 9: 803 |
Franchi L, Monteleone I, Hao LY, et al. (2017) Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis. Journal of Immunology (Baltimore, Md. : 1950) |
Guo Y, MacIsaac KD, Chen Y, et al. (2016) Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity. Cell Reports. 17: 3206-3218 |
Starke I, Johnson KM, Petersen J, et al. (2016) Binding of the immunomodulatory drug Bz-423 to mitochondrial F |
von Stockum S, Giorgio V, Trevisan E, et al. (2015) F-ATPase of Drosophila melanogaster forms 53-picosiemen (53-pS) channels responsible for mitochondrial Ca2+-induced Ca2+ release. The Journal of Biological Chemistry. 290: 4537-44 |
Hu X, Moisan J, Lesch C, et al. (2015) Abstract 4273: RORγ agonists as a novel immunotherapy approach for cancer Cancer Research. 75: 4273-4273 |
Glick GD, Rossignol R, Lyssiotis CA, et al. (2014) Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease. The Journal of Pharmacology and Experimental Therapeutics. 351: 298-307 |
Antoniel M, Giorgio V, Fogolari F, et al. (2014) The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology. International Journal of Molecular Sciences. 15: 7513-36 |
Hu X, Liu X, Morgan R, et al. (2014) Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach Journal For Immunotherapy of Cancer. 2: P194 |